Abbott receives clearance for heart delivery device in premature babies
Abbott said last week that it has received clearance to sell a device for treating life-threatening openings in the hearts of premature infants.The Food and Drug Administration clearance and CE mark position Abbott to sell its Amplatzer Piccolo Delivery System in the U.S. and the European Union.
Abbott receives clearance for heart delivery device in premature babies
Abbott said last week that it has received clearance to sell a device for treating life-threatening openings in the hearts of premature infants.The Food and Drug Administration clearance and CE mark position Abbott to sell its Amplatzer Piccolo Delivery System in the U.S. and the European Union.
Abbott receives clearance for heart delivery device in premature babies
Abbott said last week that it has received clearance to sell a device for treating life-threatening openings in the hearts of premature infants.The Food and Drug Administration clearance and CE mark position Abbott to sell its Amplatzer Piccolo Delivery System in the U.S. and the European Union.